PSMB9 and non-Hodgkin lymphoma: In HIV-negative individuals with relapsed or refractory NHL or cHL, treatment with autologous cytotoxic T lymphocytes specific for EBV antigens LMP1/LMP2 or LMP2 alone yielded encouraging results, with most patients achieving 2-year EFS with minimal toxicity [235].